A study of variation in therapeutic approach to low-risk differentiated thyroid cancer in the UK.
Autor: | Maniam P; Department of ENT, Head and Neck Surgery, NHS Lothian, Edinburgh, Scotland, UK., Ishii H; Department of ENT, Head and Neck Surgery, St George's Hospital, London, UK., Stechman MJ; Department of Endocrine Surgery, University Hospital of Wales, Cardiff, Wales, UK., Watkinson J; Department of Surgery, Great Ormond Street Hospital, London, UK., Farnell K; Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne and Wear, UK., Kim D; Department of ENT, Head and Neck Surgery, St George's Hospital, London, UK., Nixon IJ; Department of ENT, Head and Neck Surgery, NHS Lothian, Edinburgh, Scotland, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of laryngology and otology [J Laryngol Otol] 2024 Jan; Vol. 138 (1), pp. 83-88. Date of Electronic Publication: 2023 May 17. |
DOI: | 10.1017/S0022215123000841 |
Abstrakt: | Background: The British Thyroid Association and American Thyroid Association guideline definitions for low-risk differentiated thyroid cancers are susceptible to differing interpretations, resulting in different clinical management in the UK. Objective: To explore the national effect of these guidelines on the management of low-risk differentiated thyroid cancers. Methods: Anonymised questionnaires were sent to multidisciplinary teams performing thyroidectomies in the UK. Risk factors that multidisciplinary teams considered important when managing low-risk differentiated thyroid cancers were established. Results: Most surgeons (71 out of 75; 94.7 per cent) confirmed they were core multidisciplinary team members. More than 80 per cent of respondents performed at least 30 hemi- and/or total thyroidectomies per annum. A majority of multidisciplinary teams (50 out of 75; 66.7 per cent) followed British Thyroid Association guidelines. Risk factors considered important when managing low-risk differentiated thyroid cancers included: type of tumour histology findings (87.8 per cent), tumour size of greater than 4 cm (86.5 per cent), tumour stage T Conclusion: Management of low-risk differentiated thyroid cancers is highly variable, leading to a heterogeneous patient experience. |
Databáze: | MEDLINE |
Externí odkaz: |